Syndax Pharmaceuticals In...

NASDAQ: SNDX · Real-Time Price · USD
15.71
0.98 (6.65%)
At close: Aug 15, 2025, 3:59 PM
15.74
0.22%
After-hours: Aug 15, 2025, 04:10 PM EDT

Syndax Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
23.68M n/a n/a 139.71M
Cost of Revenue
826K 12K 454K 456K
Gross Profit
22.85M -12K -454K 139.25M
Operating Income
-339.67M -229.95M -151.76M 26.22M
Interest Income
26.09M 21.16M 5.87M 403K
Pretax Income
-318.76M -209.36M -149.34M 24.93M
Net Income
-318.76M -209.36M -143.75M 24.93M
Selling & General & Admin
120.88M 66.92M 33.26M 25.24M
Research & Development
241.65M 163.02M 118.5M 88.25M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
362.53M 229.95M 151.76M 113.49M
Interest Expense
4.93M 208K 3.14M 1.9M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
363.35M 229.95M 151.76M 113.49M
Income Tax Expense
n/a n/a -5.59M -43K
Shares Outstanding (Basic)
85.62M 70.26M 60.76M 52.06M
Shares Outstanding (Diluted)
85.62M 70.37M 60.76M 53.62M
EPS (Basic)
-3.73 -2.98 -2.37 0.48
EPS (Diluted)
-3.73 -2.98 -2.37 0.46
EBITDA
-313.82M -229.94M -151.76M 27.28M
EBIT
-313.83M -229.95M -146.2M 26.82M
Depreciation & Amortization
8K 12K 454K 456K